Please assess the completion status of the following clinical trial:

Trial Title: The Effect of Enoxaparin Sodium on the Incidence of Deep Vein Thrombosis Following Electrophysiology Studies and Radiofrequency Ablation.

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Patients undergoing EPS/RFA for the diagnosis and or treatment of SVT based on patient history or ECG evidence.~Exclusion Criteria:~* Patients with a past history of DVT or PE.~* Patients with a history of clotting disorders~* Patients with active malignancies~* Patients requiring full heparinisation during and after the procedure.~* Chronic atrial flutter and atrial fibrillation ablation

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 80 Years
- Healthy Volunteers: t

Study Arms:
- clexane (Type: ACTIVE_COMPARATOR): patients received clexane
- non clexane (Type: NO_INTERVENTION): no clexane given

Based on this trial design, predict the completion outcome and termination type (if applicable).